Use of botulinum toxin in the management of dystonia in Parkinson’s disease
Botulinum toxin is one of the most potent neurotoxins, but when injected into an overactive muscle, it can transiently alleviate an involuntary movement, such as dystonia. The primary aim of this article is to provide a comprehensive review of the various forms of dystonia observed in patients with...
Main Authors: | Charenya Anandan, Joseph Jankovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2024.1371601/full |
Similar Items
-
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
by: Lauren L. Spiegel, et al.
Published: (2020-05-01) -
Botulinum Toxin in Movement Disorders: An Update
by: Charenya Anandan, et al.
Published: (2021-01-01) -
Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
by: Leplow B, et al.
Published: (2017-09-01) -
Botulinum toxin therapy in Parkinson disease-related lower limb dystonia. An 8 year retrospective review
by: Antonia Schonwald, et al.
Published: (2024-01-01) -
The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia
by: Urban M. Fietzek, et al.
Published: (2021-05-01)